Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ophthalmic Devices Panel

This article was originally published in The Gray Sheet

Executive Summary

FDA downclassification of ocular prosthetic (artificial eye) lubricating solution from Class III to Class II is supported in a unanimous (9-0) vote at a Jan. 14 meeting in Rockville, Maryland. The panel recommended that manufacturers follow May 1, 1997 "Premarket Notification 510(k) Guidance for Contact Lens Products" as a special control. The panel also reviewed implantable and exterior eyelid weights for gravity-assisted treatment of lagophthalmos resulting from temporary or permanent facial paralysis - specifically of the orbicularis oculi muscle. The panel voted 9-0 to classify the previously unclassified implantable eyelid weights as Class II, with design controls and labeling as special controls; and the panel voted 7-2 to reclassify exterior eyelid weights from Class I to Class II exempt, with labeling as special controls
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT012830

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel